http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020135344-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ae1ffe37c5b16e0b0579825b48c1ca66 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-48 |
| filingDate | 2019-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_422f739840cbc2946b90f7bb4f660862 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc927dd741425317f2c26b925519c40a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17882aba02820bfe2e09f5644527a048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9070300940db9b2846b5aa0e6b448d54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6583001952efa38716e2499b8f7d3c7d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4373d4d9834deaf3ddb2321e64a11f62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7cabe5423bfcddda52eb57ccbf85de0c |
| publicationDate | 2020-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2020135344-A1 |
| titleOfInvention | Application of human endometrium endothelial projenitor cells in improving cardiomyocyte damage |
| abstract | The present invention relates to an application of human endometrium endothelial progenitor cells in improving cardiomyocyte damage. Resuspending human endometrium endothelial progenitor cells in a phosphate buffer saline PBS to form a stem cell preparation, injecting locally into a damaged portion of the heart of a model rat, performing a heart color ultrasound to observe changes in heart function, performing positron emission tomography - computed tomography (PET-CT) to observe cardiomyocyte activity and energy metabolism, performing Masson staining to observe a degree of fibrosis, and displaying a comparison to human mesenchymal stem cells; human endometrium endothelial progenitor cells have better effects on improving cardiomyocyte activity, energy metabolism, heart fibrosis, etc., and ultimately achieve the aim of repairing a damaged heart. The human endometrium endothelial progenitor cell preparation provided in the present invention may act as a medication for improving damaged cardiomyocyte activity and function, for application to diseases of the cardiovascular system. |
| priorityDate | 2018-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 107.